Solventum Corporation (NYSE:SOLV) Shares Sold by SG Americas Securities LLC

SG Americas Securities LLC trimmed its stake in shares of Solventum Corporation (NYSE:SOLV - Free Report) by 72.0% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 5,366 shares of the company's stock after selling 13,817 shares during the period. SG Americas Securities LLC's holdings in Solventum were worth $408,000 at the end of the most recent quarter.

Several other institutional investors have also modified their holdings of the stock. Vanguard Group Inc. lifted its stake in Solventum by 0.5% in the 4th quarter. Vanguard Group Inc. now owns 16,266,893 shares of the company's stock valued at $1,074,591,000 after buying an additional 75,631 shares in the last quarter. Trian Fund Management L.P. raised its holdings in shares of Solventum by 18.8% during the fourth quarter. Trian Fund Management L.P. now owns 8,462,819 shares of the company's stock valued at $559,054,000 after acquiring an additional 1,336,564 shares during the last quarter. Geode Capital Management LLC lifted its position in shares of Solventum by 3.4% in the fourth quarter. Geode Capital Management LLC now owns 3,460,405 shares of the company's stock valued at $227,992,000 after acquiring an additional 112,686 shares in the last quarter. Norges Bank acquired a new stake in shares of Solventum in the fourth quarter worth approximately $203,740,000. Finally, Invesco Ltd. boosted its stake in shares of Solventum by 6.4% in the fourth quarter. Invesco Ltd. now owns 2,923,119 shares of the company's stock worth $193,101,000 after acquiring an additional 176,201 shares during the last quarter.

Analyst Ratings Changes

Several research analysts recently commented on the company. Morgan Stanley increased their price objective on Solventum from $73.00 to $80.00 and gave the company an "equal weight" rating in a research note on Wednesday, March 5th. Mizuho upped their target price on shares of Solventum from $70.00 to $82.00 and gave the stock a "neutral" rating in a report on Monday, March 3rd. Piper Sandler raised shares of Solventum from a "neutral" rating to an "overweight" rating and raised their price target for the stock from $78.00 to $87.00 in a research note on Monday, May 19th. Wells Fargo & Company boosted their price target on shares of Solventum from $73.00 to $75.00 and gave the stock an "equal weight" rating in a research report on Friday, February 28th. Finally, KeyCorp assumed coverage on shares of Solventum in a research note on Friday, June 6th. They set a "sector weight" rating for the company. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating and two have issued a buy rating to the company's stock. Based on data from MarketBeat, the company presently has a consensus rating of "Hold" and a consensus target price of $80.29.

Solventum Trading Up 1.0%

Shares of NYSE SOLV traded up $0.75 during trading on Friday, hitting $75.38. 1,036,115 shares of the company were exchanged, compared to its average volume of 1,129,377. The company has a fifty day moving average price of $71.48 and a 200-day moving average price of $71.87. The company has a debt-to-equity ratio of 2.40, a quick ratio of 0.85 and a current ratio of 1.19. The firm has a market capitalization of $13.04 billion, a PE ratio of 34.90, a P/E/G ratio of 1.93 and a beta of 0.54. Solventum Corporation has a 12-month low of $47.16 and a 12-month high of $85.92.

Solventum (NYSE:SOLV - Get Free Report) last issued its earnings results on Thursday, May 8th. The company reported $1.34 EPS for the quarter, topping analysts' consensus estimates of $1.19 by $0.15. Solventum had a net margin of 4.55% and a return on equity of 31.01%. The company had revenue of $2.07 billion for the quarter, compared to the consensus estimate of $2.02 billion. During the same period in the previous year, the firm earned $2.08 earnings per share. Solventum's quarterly revenue was up 2.7% compared to the same quarter last year. As a group, equities research analysts expect that Solventum Corporation will post 6.58 EPS for the current year.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.